/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on.
/PRNewswire/ The global liposomal products market size is estimated to grow by USD 3,183.63 million from 2022 to 2027, according to Technavio. The market is.
Innocan Pharma Announces First Patent Grant in the United States streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
This is the first fully granted patent of Innocan in the United StatesThe Patent covers Innocan's proprietary cannabis-based pain relief topical This serves as an indication of Innocan's growing intellectual
Recent years have seen a dramatic increase in the creation of impact-oriented companies. Alongside this, investments in the field have grown as well. Thus, for example, according to a 2020 report by US SIF Foundation, sustainable investing assets in the US totaled $17.1 trillion, a 42% increase over 2018. US SIF has published a report on this area every two years since 1995, when sustainable assets totaled $639 billion.